iShares Biotechnology ETF : IBB

All IBB Articles

56 Articles

Chris Lange | Jul 12, 2017 at 1:25 PM EDT

Merrill Lynch’s Top 4 Internet Stocks for the Second Half of 2017

Merrill Lynch singled out a group in the tech sector that the firm believes will outperform going forward -- specifically,…

Chris Lange | Jul 11, 2017 at 12:10 PM EDT

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's…

Trey Thoelcke | Dec 30, 2016 at 11:15 AM EST

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

2016 was hard for biotech stocks, some more than others. These three present a buy low opportunity.

Jon C. Ogg | Dec 7, 2016 at 12:40 PM EST

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

Trump told Time that he wants to lower drug prices, a move that has hit the drug and biotech segments…

Chris Lange | Aug 9, 2016 at 11:55 AM EDT

Why We Could Expect a Zika Rally in These Stocks

We know that the broad markets work on the basis of greed and fear, but we have to ask ourselves…

Trey Thoelcke | May 26, 2016 at 9:35 AM EDT

Capital Infusions Are More Evidence of a Biotech Turnaround

Here are four biotech companies that have just either closed fresh financing rounds or issued IPOs that exceeded price expectations.

Trey Thoelcke | Apr 8, 2016 at 7:35 AM EDT

3 Stocks With Catalysts That Could Capitalize on Biotech Momentum

If the momentum in biotech can continue, then companies with catalysts within the next 12 to 18 months could get…

Chris Lange | Mar 23, 2016 at 11:15 AM EDT

Jefferies Identifies 5 Top Biotech Stocks for Huge Upside

Jefferies believes most of the significant biotech downside already occurred, though volatility could continue in the near term.

Jon C. Ogg | Feb 25, 2016 at 5:15 PM EST

Why Citi Sees Huge Upside in 4 Top Biotechs Now

Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four…

Trey Thoelcke | Dec 18, 2015 at 7:10 AM EST

4 Top Biotech Stocks for 2016

Biotech looks set to close out 2015 as its worst performing year since 2008. But can we expect a better…

Trey Thoelcke | Oct 22, 2015 at 8:25 AM EDT

The Strongest Performing Biotech in 2015 Is a Surprise

ThinkstockBiotech is still in a rut for 2015, with stocks year to date being essentially unchanged. Since January 1, the…

Jon C. Ogg | Sep 30, 2015 at 2:40 PM EDT

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

A report on Wednesday from Janney Capital Markets has targeted several iotech bcompanies it believes are now grossly oversold.

Jon C. Ogg | Sep 21, 2015 at 1:20 PM EDT

The Political Tweet That Thrashed the Biotech Sector

On Monday, a simple tweet from presidential candidate Hillary Clinton managed to wreck the biotech sector.

Trey Thoelcke | Jun 25, 2015 at 10:05 AM EDT

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

If you missed the biotech run and want to try to catch the train this late in the game, it…

Paul Ausick | Apr 21, 2015 at 11:35 AM EDT

Will Amgen Earnings Shape Biotech for the Rest of 2015?

After markets close on Tuesday, Amgen, the second-largest biotech, is scheduled to announce its first-quarter results.

1 2 3 4

iShares Biotechnology ETF : IBB

All IBB Articles

Merrill Lynch’s Top 4 Internet Stocks for the Second Half of 2017

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

Why We Could Expect a Zika Rally in These Stocks

Capital Infusions Are More Evidence of a Biotech Turnaround

3 Stocks With Catalysts That Could Capitalize on Biotech Momentum

Jefferies Identifies 5 Top Biotech Stocks for Huge Upside

Why Citi Sees Huge Upside in 4 Top Biotechs Now

4 Top Biotech Stocks for 2016

The Strongest Performing Biotech in 2015 Is a Surprise

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

The Political Tweet That Thrashed the Biotech Sector

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

Will Amgen Earnings Shape Biotech for the Rest of 2015?

3 Growth Stocks That Could Be Due for a Face-Ripping Rally in 2026

Mark Cuban Hates Trump but Loves Kid Savings Accounts — Will He Shock Everyone?

Americans Fear Running Out of Money More Than Death. Could This Be a Solution?

At What Age Do You Plan To Retire?

Suze Orman's New Year Reminder Is Spot On If You Want To Be Wealthy

3 Growth Stocks That Could Be Due for a Face-Ripping Rally in 2026

Mark Cuban Hates Trump but Loves Kid Savings Accounts — Will He Shock Everyone?

iShares Biotechnology ETF : IBB

All IBB Articles

Merrill Lynch’s Top 4 Internet Stocks for the Second Half of 2017

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

Why We Could Expect a Zika Rally in These Stocks

Capital Infusions Are More Evidence of a Biotech Turnaround

3 Stocks With Catalysts That Could Capitalize on Biotech Momentum

Jefferies Identifies 5 Top Biotech Stocks for Huge Upside

Why Citi Sees Huge Upside in 4 Top Biotechs Now

4 Top Biotech Stocks for 2016

The Strongest Performing Biotech in 2015 Is a Surprise

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

The Political Tweet That Thrashed the Biotech Sector

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

Will Amgen Earnings Shape Biotech for the Rest of 2015?

3 Growth Stocks That Could Be Due for a Face-Ripping Rally in 2026

Mark Cuban Hates Trump but Loves Kid Savings Accounts — Will He Shock Everyone?

Americans Fear Running Out of Money More Than Death. Could This Be a Solution?

Featured Reads

At What Age Do You Plan To Retire?

Suze Orman's New Year Reminder Is Spot On If You Want To Be Wealthy